3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
INDUSTRY
25
OTHER
6
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Esophageal Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
3
Small Cell Lung Carcinoma
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Thymoma
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Skin Diseases
1
Recurrence
1
Rectal Neoplasms
1
Pain
1
Neutropenia
1
Neoplasms by Site
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer
1
Gastric Adenocarcinoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma, Ductal, Breast
1
Carcinoma
1
Cancer Pain
1
Breast Diseases
1
Interventions
Docetaxel
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
UNKNOWN
×
Neoplasms by Site
×
Clear all
NCT01917279
2020-07-23
CAMELLIA
ChineseAMS
Phase 3
Unknown
280 enrolled